ATE81006T1 - Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen. - Google Patents

Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen.

Info

Publication number
ATE81006T1
ATE81006T1 AT87100195T AT87100195T ATE81006T1 AT E81006 T1 ATE81006 T1 AT E81006T1 AT 87100195 T AT87100195 T AT 87100195T AT 87100195 T AT87100195 T AT 87100195T AT E81006 T1 ATE81006 T1 AT E81006T1
Authority
AT
Austria
Prior art keywords
diltiazem
verapamil
activity
nifedipin
administration
Prior art date
Application number
AT87100195T
Other languages
English (en)
Inventor
Frank W Marcoux
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE81006T1 publication Critical patent/ATE81006T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT87100195T 1986-01-10 1987-01-09 Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen. ATE81006T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/818,505 US4654372A (en) 1986-01-10 1986-01-10 Method for using verapamil for treating stroke
EP87100195A EP0229644B1 (de) 1986-01-10 1987-01-09 Verfahren zur Anwendung von Diltiazem, Verapamil oder Nifedipin mit Aktivität zur Behandlung von Schlaganfällen

Publications (1)

Publication Number Publication Date
ATE81006T1 true ATE81006T1 (de) 1992-10-15

Family

ID=25225695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100195T ATE81006T1 (de) 1986-01-10 1987-01-09 Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen.

Country Status (8)

Country Link
US (1) US4654372A (de)
EP (1) EP0229644B1 (de)
JP (1) JPS62167725A (de)
AT (1) ATE81006T1 (de)
CA (1) CA1284950C (de)
DE (1) DE3781904T2 (de)
ES (1) ES2046178T3 (de)
GR (1) GR3005998T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
US5182276A (en) * 1989-06-16 1993-01-26 Santen Pharmaceutical Co., Ltd. Nootropic agent
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
PT1096932E (pt) * 1998-07-10 2007-09-21 Novartis Pharma Ag ''combinação anti-hipertensiva de valsartan e bloqueadores do canal de cálcio''
US20100041691A1 (en) * 2006-09-12 2010-02-18 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
MX2022013029A (es) * 2020-04-17 2023-01-16 Honeybrains Llc Composiciones y metodos para el tratamiento de trastornos neuropsiquiatricos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
JPS60130517A (ja) * 1983-12-16 1985-07-12 Mitsui Pharmaceut Inc アレルギ−性鼻炎治療剤

Also Published As

Publication number Publication date
ES2046178T3 (es) 1995-04-01
EP0229644B1 (de) 1992-09-30
GR3005998T3 (de) 1993-06-07
EP0229644A2 (de) 1987-07-22
CA1284950C (en) 1991-06-18
US4654372A (en) 1987-03-31
JPS62167725A (ja) 1987-07-24
DE3781904T2 (de) 1993-02-25
DE3781904D1 (de) 1992-11-05
EP0229644A3 (en) 1989-11-23

Similar Documents

Publication Publication Date Title
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE3752141D1 (de) Mittel zur behandlung von neuropathie
ATE22657T1 (de) Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3780091D1 (de) Behandlung von pilzinfektionen.
DE3674246D1 (de) Behandlung von sauerem kohlenwasserstoffdestillat.
ATE81006T1 (de) Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen.
DE3777861D1 (de) Behandlung von gasen.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE3888994D1 (de) Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen.
DE3889416D1 (de) Wärmebeständiges Schmiermittel zur Behandlung von Kunstfasern.
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
AT382619B (de) Verfahren zur herstellung von neuen optisch aktiven und racemischen trans- und/oder cis-1-(2'-(alkoxycarbonyl)-2'-(hydroxyimino) -aethyl)-1-alkyl-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)chinolizinen
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE3781279D1 (de) Verfahren zur behandlung von blut.
DE3751974D1 (de) Serotonin-Antagonisten zur Behandlung von Wunden
DE3751510D1 (de) Düse zur Behandlung von Fäden.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
ATE71307T1 (de) Verfahren zur behandlung von kontaktlinsen.
DE3486005D1 (de) Anwendung von carbamate oder thiocarbamat-derivaten zur behandlung von fungus-infektionen.
DE3865484D1 (de) Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid.
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
DE3764020D1 (de) Verfahren zur katalytischen hydrobehandlung von kohlenwasserstoffen.
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ATE74537T1 (de) Behandlung von gebrauchten antimonhalidkatalysatoren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee